Global Dry Powder Inhalation Capsules Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Inhalation capsules are a new and successful technique for directly delivering drugs to the respiratory system, providing a focused approach to treating a variety of respiratory disorders. These capsules, also known as dry powder inhalers (DPIs), have gained popularity in the field of respiratory medicine due to their ease of use, portability, and ability to provide immediate relief for people suffering from asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
According to our (Global Info Research) latest study, the global Dry Powder Inhalation Capsules market size was valued at US$ 859 million in 2023 and is forecast to a readjusted size of USD 1317 million by 2030 with a CAGR of 6.2% during review period.
One of the primary factors leading to inhalation capsules' adoption is their quick onset of action. Unlike oral drugs, which need to pass through the digestive system, inhalation permits the drug to be directly absorbed into the circulation via the respiratory system. This leads to faster therapeutic effects, making inhalation capsules especially useful in instances when a speedy reaction is required, such as emergency treatments or treating acute symptoms. Furthermore, inhalation capsules are ideal for elderly and pediatric patients since they avoid the difficulties associated with ingesting pills or tablets. Inhalation may be a more appealing and less threatening way for children to take medicines.
This report is a detailed and comprehensive analysis for global Dry Powder Inhalation Capsules market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Dry Powder Inhalation Capsules market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Dry Powder Inhalation Capsules market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Dry Powder Inhalation Capsules market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Dry Powder Inhalation Capsules market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dry Powder Inhalation Capsules
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dry Powder Inhalation Capsules market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Capsugel (Lonza), ACG, Qualicaps, HealthCaps India, Cipla, Boehringer Ingelheim GmbH, Elpen S.A., Vectura Group Plc, CHIESI Farmaceutici S.p.A., AstraZeneca Plc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Dry Powder Inhalation Capsules market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Gelatin Capsules
Hypromellose Capsules
Market segment by Application
Asthma Treatment
COPD Management
Others
Major players covered
Capsugel (Lonza)
ACG
Qualicaps
HealthCaps India
Cipla
Boehringer Ingelheim GmbH
Elpen S.A.
Vectura Group Plc
CHIESI Farmaceutici S.p.A.
AstraZeneca Plc
Novartis
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dry Powder Inhalation Capsules product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dry Powder Inhalation Capsules, with price, sales quantity, revenue, and global market share of Dry Powder Inhalation Capsules from 2019 to 2024.
Chapter 3, the Dry Powder Inhalation Capsules competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dry Powder Inhalation Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Dry Powder Inhalation Capsules market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dry Powder Inhalation Capsules.
Chapter 14 and 15, to describe Dry Powder Inhalation Capsules sales channel, distributors, customers, research findings and conclusion.